CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shenzhen Hepalink Pharmaceutical Company Limited Company Snapshot
Shenzhen Hepalink Pharmaceutical Company Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Hepalink Pharmaceutical Company Limited with three other companies in this sector in China: Shandong Lukang Pharmaceutical (2016 sales of 2.51 billion Chinese Renmimbi [US$363.86 million] of which 67% was Human Antibiotic), PKU HealthCare Corp Ltd (2.07 billion Chinese Renmimbi [US$300.63 million] of which 86% was Merchandise&Material Selling), and Zhejiang Jianfeng Group Company Limited (2.38 billion Chinese Renmimbi [US$345.49 million] of which 45% was Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at Shenzhen Hepalink Pharmaceutical Company Limited were 2.26 billion Chinese Renmimbi (US$328.16 million). This is a decrease of 1.3% versus 2015, when the company's sales were 2.29 billion Chinese Renmimbi. The sales level in 2016 was fairly close to the level five years ago: in 2011, Shenzhen Hepalink Pharmaceutical Company Limited had sales of 2.49 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 69.7% decline in Other Operating, from 1.21 million Chinese Renmimbi to 367,490.08 Chinese Renmimbi. There were also decreases in sales in Pharmaceutical Manufacturing (down 1.3% to 2.26 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shenzhen Hepalink Pharmaceutical Company Limited
  Stock Performance Chart for Shenzhen Hepalink Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (4/27/2017): 20.48
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
Shenzhen Hepalink Pharmaceutical Company Limited Key Data:
  Ticker: 002399 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2016 Sales 2,259,464,572
(Year Ending Jan 2017).
Employees: 1,913
  Currency: Chinese Renmimbi Market Cap: 25,542,690,898
  Fiscal Yr Ends: December Shares Outstanding: 1,247,201,704
  Share Type: Gu Closely Held Shares: 995,165,506
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.